FDA Import Refusal 112-2320434-3/1/1 — Novartis Pharmaceuticals Corporation
The FDA refused shipment 112-2320434-3/1/1 from Novartis Pharmaceuticals Corporation (United States) on June 4, 2012. The refused product falls under Drugs and Biologics — METHYLPHENIDATE HCL (STIMULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- June 4, 2012
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 66BCB19 METHYLPHENIDATE HCL (STIMULANT)
- Charges
- 75